ANGEN vs ECILC Comparison
Price, market cap, valuation, profitability and leverage metrics of ANGEN and ECILC side by side.
If you had invested TRY 10,000
Metric comparison
| Metric | ANGEN | ECILC | Sector median |
|---|---|---|---|
| Last price (TL) | 6.92 | 64.60 | 18.72 |
| Daily change | −2.40% | −5.69% | −4.53% |
| Market cap | TRY 1.5B | TRY 44.3B | TRY 4.4B |
| P/B | 1.07 | 0.68 | 1.14 |
| Dividend yield | — | 2.04% | 0.90% |
| Return on equity | −18.02% | −3.08% | 1.78% |
| Free float | 35.53% | 22.02% | 37.21% |
Popular comparisons
Related pages
About the ANGEN vs ECILC comparison
Price, market cap, valuation multiples, profitability and leverage of ANGEN (Anatolia Tani ve Biyoteknoloji) and ECILC (Eczacıbaşı İlaç) side by side as of Sep 28, 2026, 11:41. Of the 15 metrics compared, ANGEN leads in 7 and ECILC leads in 8.
Highlights: Daily change: ANGEN leads (−2.40% vs −5.69%). Market cap: ECILC leads (TRY 44.3B vs TRY 1.5B). P/B: ECILC leads (0.68 vs 1.07). EV/EBITDA: ANGEN leads (46.57 vs 165.19). EV/Sales: ANGEN leads (5.88 vs 9.35). Gross margin: ANGEN leads (55.69% vs 37.83%). EBITDA margin (annual): ANGEN leads (28.18% vs 11.49%). Net margin (annual): ECILC leads (−20.86% vs −42.01%).
Frequently asked questions
Is ANGEN or ECILC cheaper?
By P/E, Tie is cheaper (— vs —); by P/B, ECILC trades at the lower multiple (1.07 vs 0.68).
Which is more profitable, ANGEN or ECILC?
Annual net margin is −42.01% for ANGEN and −20.86% for ECILC; return on equity is −18.02% for ANGEN and −3.08% for ECILC.
Which is more leveraged, ANGEN or ECILC?
The leverage ratio is 33.55 for ANGEN and 18.92 for ECILC; net debt/EBITDA is 2.34 for ANGEN and 1.37 for ECILC. Lower values mean less leverage.
Where does the comparison data come from?
Prices and market caps come from 15-minute delayed Borsa Istanbul data; ratios are calculated from the latest financial statements filed with KAP. Some ratios are not defined for banks and insurers.